Lipid metabolism in treated HIV Infection.

@article{Dube2011LipidMI,
  title={Lipid metabolism in treated HIV Infection.},
  author={Michael Dube and Joseph J Cadden},
  journal={Best practice & research. Clinical endocrinology & metabolism},
  year={2011},
  volume={25 3},
  pages={429-42}
}
Patients infected with the human immunodeficiency virus (HIV) are prone to a great number of lipid and lipoprotein disturbances, as a result of both the infection itself and direct effects on lipid metabolism from the drugs used to treat HIV infection. These lipid disorders account for at least part of the increased risk of cardiovascular disease seen in this population. In general, evaluation and interventions for dyslipidemia in HIV-infected individuals should follow guidelines established… CONTINUE READING
20 Citations
101 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 101 references

1281–1292

  • Flexner C. HIV-protease inhibitors. New England Journal of 1998, 33818
  • M.P. Dubé, J.J. Cadden / Best Practice & Research…
  • 2011

2506–2512

  • Lee H Hadigan C et al. Increased acute myocardial infa Triant VA, cardiovascular risk factors among patients with human immunodefic Endocrinology, Metabolism 2007 Jul, 927
  • M.P. Dubé, J.J. Cadden / Best Practice & Research…
  • 2011

the MaxCmin1 Trial

  • UB Dragsted, J Gerstoft, patients Pedersen C et al. Randomized trial to evaluate ind 1-infected
  • Journal of Infectious Diseases Sep 1 2003; 188(5…
  • 2011

Similar Papers

Loading similar papers…